Contact
searchSearch
HMP Global

Advertisement

ADVERTISEMENT

Insights

Headshot and logo for Talking Therapeutics with Douglas Jennings, PharmD
Talking Therapeutics
Cutting Through Cost Barriers for Heart Failure Medications
03/02/2023
In the latest installment of Talking Therapeutics, Dr Jennings provides a brief history of heart failure medications and discusses the cost effectiveness of quadruple, triple, and double therapy regimens.
In the latest installment of Talking Therapeutics, Dr Jennings provides a brief history of heart failure medications and discusses the cost effectiveness of quadruple, triple, and double therapy regimens.
In the latest installment of...
03/02/2023
Pharmacy Learning Network
Headshot and logo for Talking Therapeutics with Douglas Jennings, PharmD
Talking Therapeutics
ACC Updates Part 2
06/01/2021
Last week’s edition of Talking Therapeutics highlighted several new and exciting studies related to heart failure drug therapies. This week we tackle three more pivotal trials from this year’s exciting conference.
Last week’s edition of Talking Therapeutics highlighted several new and exciting studies related to heart failure drug therapies. This week we tackle three more pivotal trials from this year’s exciting conference.
Last week’s edition of Talking...
06/01/2021
Pharmacy Learning Network
Headshot of Mark Munger, PharmD
Commentary
An Update on Heart Failure: World-Wide Burden, Rural Versus Urban Adults, Ethnic Disparities, and Remote Monitoring
06/01/2021
Mark Munger, PharmD, provides up-to-date information on heart failure across the world, related mortality in rural versus urban adults, ethnic disparities in US outcomes, and potential innovations of heart failure care.
Mark Munger, PharmD, provides up-to-date information on heart failure across the world, related mortality in rural versus urban adults, ethnic disparities in US outcomes, and potential innovations of heart failure care.
Mark Munger, PharmD, provides...
06/01/2021
Pharmacy Learning Network

Advertisement

Heart Failure Treatment Insight From ACC.2021
Talking Therapeutics
Heart Failure Treatment Insight From ACC.2021
05/19/2021
In this week's installment of Talking Therapeutics, Dr Jennings offers a breakdown on the latest heart failure therapy data, which was recently presented at the American College of Cardiology's annual meeting.
In this week's installment of Talking Therapeutics, Dr Jennings offers a breakdown on the latest heart failure therapy data, which was recently presented at the American College of Cardiology's annual meeting.
In this week's installment of...
05/19/2021
Pharmacy Learning Network
Hypertension, Hyperlipidemia for Developing and Sustaining Atrial Fibrillation
Commentary
Hypertension, Hyperlipidemia for Developing and Sustaining Atrial Fibrillation
05/04/2021
“Goal-directed use of antihypertensives and statin drugs appear to be effective strategies to reduce atrial fibrillation incidence, morbidity, and mortality,” says Mark Munger, PharmD.
“Goal-directed use of antihypertensives and statin drugs appear to be effective strategies to reduce atrial fibrillation incidence, morbidity, and mortality,” says Mark Munger, PharmD.
“Goal-directed use of...
05/04/2021
Pharmacy Learning Network
V is for Victory in Heart Failure
Talking Therapeutics
V is for Victory in Heart Failure
04/28/2021
In this week’s issue of Talking Therapeutics, Dr Jennings explores the science and promise of a recently approved novel medication for patients with HFrEF.
In this week’s issue of Talking Therapeutics, Dr Jennings explores the science and promise of a recently approved novel medication for patients with HFrEF.
In this week’s issue of Talking...
04/28/2021
Pharmacy Learning Network

Advertisement

Targeting Inflammation to Treat Coronary Artery Disease
Talking Therapeutics
Targeting Inflammation to Treat Coronary Artery Disease
04/20/2021
Dr Jennings reviews evidence supporting colchicine use to further reduce residual disease burden in coronary artery disease but highlights why pharmacists need to keep several things in mind when dispensing colchicine to ensure that patients...
Dr Jennings reviews evidence supporting colchicine use to further reduce residual disease burden in coronary artery disease but highlights why pharmacists need to keep several things in mind when dispensing colchicine to ensure that patients...
Dr Jennings reviews evidence...
04/20/2021
Pharmacy Learning Network
How Do We Achieve Optimal Population Cardiovascular Health?
Commentary
How Do We Achieve Optimal Population Cardiovascular Health?
02/10/2021
Mark Munger, PharmD, professor, Pharmacotherapy and Internal Medicine, University of Utah, discusses the declining rate of cardiovascular health across the world, and highlights what pharmacists can do in order to help support the 2020 goals...
Mark Munger, PharmD, professor, Pharmacotherapy and Internal Medicine, University of Utah, discusses the declining rate of cardiovascular health across the world, and highlights what pharmacists can do in order to help support the 2020 goals...
Mark Munger, PharmD, professor,...
02/10/2021
Pharmacy Learning Network
Update on Hypertension Epidemiology and Treatment for 2021
Commentary
Update on Hypertension Epidemiology and Treatment for 2021
02/01/2021
Mark Munger, PharmD, discusses recent hypertension research and explains why treatment is important for intensive blood pressure control.
Mark Munger, PharmD, discusses recent hypertension research and explains why treatment is important for intensive blood pressure control.
Mark Munger, PharmD, discusses...
02/01/2021
Pharmacy Learning Network

Advertisement

Identifying the Important Role Pharmacists Play Among Patients Delaying PCP Care During the Pandemic
Videos
Identifying the Important Role Pharmacists Play Among Patients Delaying PCP Care During the Pandemic
11/10/2020
Andrea Russo, MD, director, Electrophysiology and Arrhythmia Services, Cooper Hospital, discusses why there have been delays among patients making primary care visits, along with the impact this has on diagnosis, and she provides tips for...
Andrea Russo, MD, director, Electrophysiology and Arrhythmia Services, Cooper Hospital, discusses why there have been delays among patients making primary care visits, along with the impact this has on diagnosis, and she provides tips for...
Andrea Russo, MD, director,...
11/10/2020
Pharmacy Learning Network

Advertisement

Advertisement

Advertisement

What's Trending?

News Connection
Novo Nordisk’s New Insulin Program Includes Free, One-Off Supply
01/27/2020
The latest solutions to more affordable treatment for people with diabetes come as three new Novo Nordisk initiatives: the My$99Insulin program, follow-on brands (FOB) of insulins, and an immediate supply option for those in need.
The latest solutions to more affordable treatment for people with diabetes come as three new Novo Nordisk initiatives: the My$99Insulin program, follow-on brands (FOB) of insulins, and an immediate supply option for those in need.
The latest solutions to more...
01/27/2020
First Report Managed Care
News
FDA Expands Use of Novartis MS Drug to Pediatric Patients
05/14/2018
The FDA has expanded the use of a multiple sclerosis drug to now include treatment of children and adolescents. 
The FDA has expanded the use of a multiple sclerosis drug to now include treatment of children and adolescents. 
The FDA has expanded the use of...
05/14/2018
Pharmacy Learning Network
News
Safety Concerns Cloud Early Promise of Powerful New Cancer Drugs
01/26/2015
A new wave of experimental cancer drugs that directly recruit the immune system's powerful T cells are proving to be immensely effective weapons against tumors, potentially transforming the $100 billion global market for drugs that fight the...
A new wave of experimental cancer drugs that directly recruit the immune system's powerful T cells are proving to be immensely effective weapons against tumors, potentially transforming the $100 billion global market for drugs that fight the...
A new wave of experimental...
01/26/2015
First Report Managed Care
News
Moderate Drinking Linked to Lower Diabetes Risk
04/28/2010
04/28/2010
First Report Managed Care
News
OAs Commonly Use Online Physician Ratings to Select Best Care Option
01/07/2020
Among recently surveyed adults who read reviews, 31% did so for a doctor they had already seen, while 65% and 34% did so for doctors they were considering seeing or to find a new doctor, respectively.
Among recently surveyed adults who read reviews, 31% did so for a doctor they had already seen, while 65% and 34% did so for doctors they were considering seeing or to find a new doctor, respectively.
Among recently surveyed adults...
01/07/2020
Annals of Long-Term Care

Advertisement

Stay Informed—Sign up today!

Population Health Newsletter

Advertisement

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use